openPR Logo
Press release

A patient’s perspective: Living with a Rare Disease

02-14-2017 03:32 PM CET | Health & Medicine

Press release from: SMi Group

In anticipation of Rare Disease Day, now is the ideal time to unite and raise awareness of the impact that rare diseases have on the lives on the patient and those who care for them amongst those who are unaware. The continued research of orphan drugs is detrimental to the rare disease community. Not forgetting the reason why the industry continually strives for optimal drug development – the patient.

Taking the stage to present the keynote for the first time ever at SMi’s Orphan Drugs conference, will be Carol McCudden, Patient Ambassador and Julie Research Officer from Ataxia UK.

The opening address will introduce the challenges of the ataxias, a set of rare degenerative neurological conditions, covering the following areas:

• Patient experience of being a patient living with ataxia, her strategies for living with the condition, and her engagement as a patient with the NHS.
• An overview of the challenges for Ataxia UK, as a patient group working with a set of rare conditions with no treatments or cures.
• Their research strategy, partnerships with pharmaceutical companies and others, and the progress which has been made to date.

Alastair Kent, Director, Genetic Alliance UK and Giorgio Iotti, Medical Scientific Manager – Rare Diseases Unit, Chiesi Farmaceutici have also shared their views on the costly yet essential endeavor that is critical to development of treatments for rare diseases.

“...Current pricing and reimbursement mechanisms are coming under increasing pressure as the number of innovative therapies for rare diseases continues to grow. We will need to look carefully at how to make patient access equitable and sustainable in the medium to long term if progress is to be made and unmet medical needs satisfied..."
Alastair Kent, Director, Genetic Alliance UK

“I can understand that price is different in the various countries but for pharma companies the real nightmare is satisfying different requests raised by reimbursement authorities in each of the country in which the product is to be marketed. The second aspect is to design innovative payment schemes (like annualized installments) for reimbursement of advanced therapies in which single interventions are foreseen..."
Giorgio Iotti, Medical Scientific Manger, Rare Diseases Unit, Chiesi Farmaceutici

To read the full interviews, visit the download centre on www.orphandrugs-event.com/openpr

There is currently a £200 early bird discount for all bookings made before 28th February.

Orphan Drugs and Rare Diseases Europe 2017
15th – 16th May 2017
Berlin, Germany
www.orphandrugs-event.com/openpr

Follow the conversation on Twitter and LinkedIn at #smiorphandrugseurope

SMi Group
Ground & First Floor
1 Westminster Bridge Road
London, SE1 7XW

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release A patient’s perspective: Living with a Rare Disease here

News-ID: 437457 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Rare

lacit Market With Industrial Analysis by Forecast 2020-2025 | China Minmetals Ra …
This report provides in-depth study on the current state of the Global Lacit Market 2020-2025. Key players in the Global Lacit Market have been identified through the secondary research and their market share has been determined through primary and secondary research. Global Lacit Market overview: It is a compound made from lanthanum acetate and citric acid. LaCit market is segmented by Type, and by Application. Players, stakeholders, and other participants in the
What's driving the Rare Earth Metals Market growth? Great Western Minerals, Indi …
GMI presents a most up-to-date research on “Rare Earth Metals Market”– Global Industry Analysis, Size, Share, By Metal (Cerium, Dysprosium, Erbium, Europium, Gadolinium, Holmium, Lanthanum, Lutetium, Neodymium, Praseodymium, Promethium, Samarium, Scandium, Terbium, Thulium, Ytterbium, Yttrium), By Application (Magnets, Colorants, Alloys, Optical Instruments, Catalysts) Growth Potential, Trends Statistics, Regional Outlook (U.S., Canada, France, Germany, UK, Russia, Italy, China, India, Japan, Australia, Thailand, Malaysia, Brazil, Mexico, GCC) and Forecast 2017 – 2024”. According
Global Erbium Oxide Market 2017 - Chenguang Rare Earth, Longyi Heavy Rare-Earth, …
The report studies Erbium Oxide in Global market Professional Survey 2017 : Size, Share, Trends, Industry Growth, Opportunity, Application, Production, Segmentation, Cost Structure, Company Profile, Product Picture and Specifications during the Forecast period by 2022 The report Global Erbium Oxide Industry provides a comprehensive analysis of the Erbium Oxide market. The report features industry insights from experts. A detailed segmentation of the Global Erbium Oxide market has been included in the
Global Dysprosium Oxide Market 2017 - Longyi Heavy Rare-Earth, China Minmetals R …
The report studies Dysprosium Oxide in Global market Professional Survey 2017 : Size, Share, Trends, Industry Growth, Opportunity, Application, Production, Segmentation, Cost Structure, Company Profile, Product Picture and Specifications during the Forecast period by 2022 The report Global Dysprosium Oxide Industry 2017 is a professional, in-depth study that includes insights extracted from complex information, which clients can use for their business advantage. A large volume of precise, reliable market data has
Global Europium Oxide Market 2017 - Longyi Heavy Rare-Earth, China Minmetals Rar …
The report studies Europium Oxide in Global market Professional Survey 2017 : Size, Share, Trends, Industry Growth, Opportunity, Application, Production, Segmentation, Cost Structure, Company Profile, Product Picture and Specifications during the Forecast period by 2022 The research report titled Europium Oxide has adopted an analytical approach to evaluate the dynamics of the Europium Oxide market. It provides a detailed analysis comprising an in-depth research on the Europium Oxide market growth drivers,
Global Rare Earth Metals Market 2017 - Beifang Rare Earth, Xiamen Tungsten, Sunl …
Rare Earth Metals Market 2017 Industry research report provides important information to identify and analyze the market need, market size and competition. This market research report used in maintaining competitiveness over competitors. Scope of the Report: This report focuses on the Rare Earth Metals in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.